IL17A and neoplasm: For example, microbial products induce invasive colonic adenomas, leading to barrier deterioration during the tumor initiation phase, which increases the production of IL-23 and downstream cytokines like IL-17 and IL-22 that directly promote the growth of cancer cells in CRC, liver cancer [40], or pancreatic cancer.